Advertisement Vacci-Test wins CE mark for tetanus test - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Vacci-Test wins CE mark for tetanus test

Vacci-Test Corporation of Calgary, Alberta, Canada has announced that its subsidiary, Vacci-Test Europe, has received the CE mark for its first product, Vacci-Test Tetanus.

Vacci-Test Tetanus is a rapid, sensitive, lateral flow diagnostic test to determine the immune status of an individual by detecting the presence of circulating antibodies. This time saving, precise diagnostic device is said to allow emergency and point-of-care physicians to determine if a patient needs to be revaccinated.

Since Vacci-Test Tetanus is intended for use as a diagnostic tool in humans the receipt of the CE mark is the last approval step before marketing the product. The CE mark signifies that the product complies with all health, safety and environmental directives of the EU.